Crescita Therapeutics (TSE:CTX) Announces Earnings Results

Crescita Therapeutics (TSE:CTX) released its quarterly earnings results on Monday. The company reported C($0.06) earnings per share for the quarter, FiscalAI reports. The business had revenue of C$5.64 million during the quarter. Crescita Therapeutics had a negative return on equity of 0.59% and a negative net margin of 0.44%.

Crescita Therapeutics Stock Performance

TSE CTX opened at C$0.76 on Tuesday. The stock has a 50-day moving average of C$0.68 and a 200 day moving average of C$0.55. Crescita Therapeutics has a twelve month low of C$0.40 and a twelve month high of C$0.76. The stock has a market capitalization of C$14.15 million, a price-to-earnings ratio of 37.50 and a beta of -1.34. The company has a current ratio of 3.33, a quick ratio of 2.29 and a debt-to-equity ratio of 2.14.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.